271 related articles for article (PubMed ID: 25424813)
1. Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States.
Weycker D; Atwood MA; Standaert B; Krishnarajah G
Hum Vaccin Immunother; 2014; 10(7):2032-8. PubMed ID: 25424813
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
[TBL] [Abstract][Full Text] [Related]
3. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
[TBL] [Abstract][Full Text] [Related]
4. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
[TBL] [Abstract][Full Text] [Related]
5. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.
Weycker D; Sofrygin O; Kemner JE; Pelton SI; Oster G
Vaccine; 2009 Aug; 27(36):4930-7. PubMed ID: 19555715
[TBL] [Abstract][Full Text] [Related]
6. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Cortese MM; Parashar UD;
MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).
Dennehy PH; Vesikari T; Matson DO; Itzler RF; Dallas MJ; Goveia MG; DiNubile MJ; Heaton PM; Ciarlet M
Hum Vaccin; 2011 May; 7(5):563-8. PubMed ID: 21441783
[TBL] [Abstract][Full Text] [Related]
8. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
[TBL] [Abstract][Full Text] [Related]
9. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
Bégué RE; Perrin K
Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
[TBL] [Abstract][Full Text] [Related]
11. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.
Payne DC; Selvarangan R; Azimi PH; Boom JA; Englund JA; Staat MA; Halasa NB; Weinberg GA; Szilagyi PG; Chappell J; McNeal M; Klein EJ; Sahni LC; Johnston SH; Harrison CJ; Baker CJ; Bernstein DI; Moffatt ME; Tate JE; Mijatovic-Rustempasic S; Esona MD; Wikswo ME; Curns AT; Sulemana I; Bowen MD; Gentsch JR; Parashar UD
Clin Infect Dis; 2015 Dec; 61(12):1792-9. PubMed ID: 26449565
[TBL] [Abstract][Full Text] [Related]
12. Spotlight on pentavalent rotavirus vaccine (RotaTeq) in the prevention of rotavirus gastroenteritis in Europe.
Plosker GL
BioDrugs; 2010 Dec; 24(6):411-4. PubMed ID: 21043548
[TBL] [Abstract][Full Text] [Related]
13. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
Ciarlet M; Schödel F
Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
[TBL] [Abstract][Full Text] [Related]
14. Rotavirus vaccines in Israel: Uptake and impact.
Muhsen K; Cohen D
Hum Vaccin Immunother; 2017 Jul; 13(7):1722-1727. PubMed ID: 28281866
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.
Payne DC; Boom JA; Staat MA; Edwards KM; Szilagyi PG; Klein EJ; Selvarangan R; Azimi PH; Harrison C; Moffatt M; Johnston SH; Sahni LC; Baker CJ; Rench MA; Donauer S; McNeal M; Chappell J; Weinberg GA; Tasslimi A; Tate JE; Wikswo M; Curns AT; Sulemana I; Mijatovic-Rustempasic S; Esona MD; Bowen MD; Gentsch JR; Parashar UD
Clin Infect Dis; 2013 Jul; 57(1):13-20. PubMed ID: 23487388
[TBL] [Abstract][Full Text] [Related]
16. Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5).
Itzler R; Koch G; Matson DO; Gothefors L; Van Damme P; Dinubile MJ; Heaton PM
BMC Pediatr; 2010 Jun; 10():42. PubMed ID: 20540778
[TBL] [Abstract][Full Text] [Related]
17. Rotavirus vaccine: a cost effective control measure for India.
Kumar A; Goel MK; Jain RB; Khanna P; Vibha V
Hum Vaccin Immunother; 2012 Apr; 8(4):501-4. PubMed ID: 23071989
[TBL] [Abstract][Full Text] [Related]
18. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
[TBL] [Abstract][Full Text] [Related]
19. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
Tapia MD; Armah G; Breiman RF; Dallas MJ; Lewis KD; Sow SO; Rivers SB; Levine MM; Laserson KF; Feikin DR; Victor JC; Ciarlet M; Neuzil KM; Steele AD
Vaccine; 2012 Apr; 30 Suppl 1():A79-85. PubMed ID: 22520141
[TBL] [Abstract][Full Text] [Related]
20. Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.
Plosker GL
Drugs; 2010 Jun; 70(9):1165-88. PubMed ID: 20518582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]